<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260926071188N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-09-30</date_registration>
      <primary_sponsor>Sport Sciences Research Institute</primary_sponsor>
      <public_title>The effect of light walking after a meal on blood sugar</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Postprandial  walking duration on serum insulin and two-hour blood glucose response in overweight women.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>15</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/93605</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Crossover, Purpose: Prevention, Randomization description: Randomization method: Simple randomization.

Unit of randomization: Individual participant.

Stratification: No stratified randomization was used.

Randomization tool: A software-based randomization procedure was used to generate the random sequence.

Generation of the random sequence: For each participant, the order of the three study conditions, including the control condition (rest), 10-minute postprandial walking, and 20-minute postprandial walking, was randomly determined. Each participant received all three conditions in three separate study sessions, with a 72-hour interval between sessions.

Allocation concealment: Because of the crossover design, each participant received all three study conditions and there was no permanent allocation to parallel intervention or control groups. The randomized order of the study conditions was not disclosed to the participant before the study schedule was determined.</study_design>
      <phase>N/A</phase>
      <hc_freetext>overweight.</hc_freetext>
      <i_freetext>Intervention 1: Control group: After consuming a standardized meal, participants remain at rest for 120 minutes and perform no exercise or training intervention during this period. Intervention 2: Intervention group: First intervention group: Immediately after consuming a standardized meal, participants walk on a treadmill for 10 minutes at a speed of 4–6 km/h. After completing the 10-minute walk, participants remain at rest until the end of the 120-minute period. Intervention 3: Intervention group: Second intervention group: Immediately after consuming a standardized meal, participants walk on a treadmill for 20 minutes at a speed of 4–6 km/h. After completing the 20-minute walk, participants remain at rest until the end of the 120-minute period.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
De-identified individual participant data, including data related to the primary and secondary outcomes of the study and the variables required to reproduce the reported analyses, will be available upon request and shareable after removal of any identifying information.

When:
Access will begin upon publication of the main study article and will continue for as long as the data remain usable for valid research purposes.

To whom:
Researchers and faculty members of universities and reputable research institutions who submit a justified research request.

Conditions:
The data will be usable solely for valid research and scientific purposes, including reanalysis of the data, reproduction of the reported analyses, or conducting secondary analyses related to the research objectives. The data will be provided in a de-identified form, and their use for re-identification of participants is not permitted.

Where to obtain:
Requests should be sent to the principal investigator of the study at the Research Institute of Physical Education and Sport Sciences.

How to obtain:
Any data sharing will be contingent upon adherence to the confidentiality of participants’ information, research ethics principles, and relevant data protection regulations.

Comments:
Any data sharing will be contingent upon adherence to the confidentiality of participants’ information, research ethics principles, and relevant data protection regulations.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Shariatzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 3, 5th Alley, Mir Emad Street, Ostad Motahari Street, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1587958711</zip>
        <telephone>+98 21 8873 3498</telephone>
        <email>shariatzadeh.sport@gmail.com</email>
        <affiliation>Sport Sciences Research Institute</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Shariatzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 3, 5th Alley, Mir Emad Street, Ostad Motahari Street, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1587958711</zip>
        <telephone>+98 21 8873 3498</telephone>
        <email>shariatzade221@yahoo.com</email>
        <affiliation>Sport Sciences Research Institute</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Female, aged 34–44                                                                                                Body Mass Index (BMI) between 25 and 30                                                                 No history of chronic or metabolic diseases (e.g., diabetes, cardiovascular disease, hormonal disorders)                                                                        Not pregnant or breastfeeding                                                                              Not taking medications that could affect blood sugar or insulin levels</inclusion_criteria>
      <agemin>34 years</agemin>
      <agemax>44 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having metabolic syndrome conditions such as diabetes, high blood pressure, etc.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>overweight</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: After consuming a standardized meal, participants remain at rest for 120 minutes and perform no exercise or training intervention during this period.</i_keyword>
      <i_keyword>Intervention group: First intervention group: Immediately after consuming a standardized meal, participants walk on a treadmill for 10 minutes at a speed of 4–6 km/h. After completing the 10-minute walk, participants remain at rest until the end of the 120-minute period.</i_keyword>
      <i_keyword>Intervention group: Second intervention group: Immediately after consuming a standardized meal, participants walk on a treadmill for 20 minutes at a speed of 4–6 km/h. After completing the 20-minute walk, participants remain at rest until the end of the 120-minute period.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Blood glucose concentration at 0, 10, 20, 60, and 120 minutes after consumption of a standardized meal, measured using an Accu-Chek Active glucometer. Timepoint: Blood glucose measurement at the beginning of each session (minute 0, before the start of the intervention) and at 10, 20, 60, and 120 minutes after consumption of a standardized meal. Method of measurement: Accu-Chek Active Blood Glucose Meter, Roche Diagnostics, Germany.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Area under the curve (AUC) of blood glucose concentration from time 0 to 120 minutes after consumption of a standardized meal. Timepoint: From time 0 to 120 minutes after consumption of a standardized meal, in each of the three study sessions. Method of measurement: Accu-Chek Active glucometer (Roche Diagnostics, Germany) using the device-specific test strips; the area under the curve will be calculated based on the measured blood glucose values using the trapezoidal method.</sec_outcome>
      <sec_outcome>Serum insulin concentration at 120 minutes after consumption of a standardized meal. Timepoint: At 120 minutes after consumption of a standardized meal, in each of the three study sessions. Method of measurement: Human insulin ELISA kit (Monobind, USA), using a microplate reader.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sport Sciences Research Institute</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-07-27</approval_date>
        <contact_name>Ethics Committee of Sport Sciences Research Institute</contact_name>
        <contact_address>No. 3, 5th Alley, Miremad Street, Motahhari Street, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
